Table 3.

The group of 24HUna/cr as an independent factor to the level of urine cytokines at 0-week^* by multiple linear regression

^*0 week, starting week for Olmesartan (40 mg per day) after a 8-wash out period of any ARB, ACEI, or aldosterone blocker; 24HUna/cr group: group according to the ratio of 24-hr urine sodium to creatinine with the criteria of 100 and 200 mEq/g cr; 24HUalb/cr: the ratio of 24-hr urine albumin to creatinine (mg/g creatinine); uAGT/cr: urine angiotensinogen to creatinine ratio (pg/mg cr); uMDA/cr: urine malondialdehyde to creatinine ratio (pM/mg cr); BB medication: beta-blocker medication; Linear regression for uAGT/cr was adjusted for age, gender, hemoglobin, 24-hr urine albumin to creatinine ratio, GFR, and group of 24HUna/cr, which were the factors related to the urine angiotensinogen to creatinine ratio at 0-week. Linear regression for uMDA/cr was adjusted for age, gender, beta-blocker, serum total CO₂, and group of 24HUna/cr.